|
Pathway ID
|
Pathway name
|
GSE71989
|
GSE15471
|
GSE16515
|
GSE32676
|
GSE41368
|
GSE28735
|
Total degree
|
|---|
|
Outd
|
Ind
|
Outd
|
Ind
|
Outd
|
Ind
|
Outd
|
Ind
|
Outd
|
Ind
|
Outd
|
Ind
|
|---|
|
05200
|
Pathway in cancer
|
28
|
0
|
21
|
0
|
15
|
0
|
23
|
0
|
21
|
0
|
8
|
0
|
116
|
|
04115
|
P53 signaling pathway
|
2
|
16
|
2
|
12
|
2
|
6
|
1
|
13
|
1
|
11
|
0
|
3
|
69
|
|
04510
|
Focal adhesion
|
8
|
7
|
7
|
5
|
6
|
4
|
6
|
5
|
7
|
6
|
3
|
4
|
68
|
|
04060
|
Cytokine-cytokine receptor interaction
|
0
|
16
|
0
|
14
|
0
|
8
|
0
|
9
|
0
|
13
|
0
|
4
|
64
|
|
04810
|
Regulation of actin cytoskeleton
|
3
|
9
|
3
|
8
|
3
|
6
|
3
|
7
|
3
|
9
|
1
|
2
|
57
|
|
00010
|
Glycolysis/Gluconeogenesis
|
2
|
14
|
0
|
6
|
3
|
11
|
0
|
4
|
2
|
10
|
1
|
3
|
56
|
|
05322
|
Systemic lupus erythematosus
|
8
|
0
|
7
|
0
|
6
|
0
|
6
|
0
|
8
|
0
|
2
|
0
|
37
|
|
05219
|
Bladder cancer
|
6
|
1
|
5
|
1
|
5
|
1
|
5
|
1
|
4
|
1
|
1
|
1
|
32
|
|
05222
|
Small cell lung cancer
|
5
|
1
|
5
|
1
|
5
|
1
|
4
|
1
|
4
|
1
|
3
|
1
|
32
|
|
04610
|
Complement and coagulation cascades
|
1
|
7
|
0
|
6
|
0
|
2
|
0
|
2
|
1
|
6
|
0
|
1
|
26
|
|
04512
|
ECM-receptor interaction
|
1
|
3
|
1
|
3
|
1
|
3
|
1
|
3
|
1
|
3
|
1
|
3
|
24
|
|
04360
|
Axon guidance
|
3
|
0
|
3
|
0
|
3
|
0
|
3
|
0
|
3
|
0
|
2
|
0
|
17
|
|
05211
|
Renal cell carcinoma
|
4
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
2
|
1
|
0
|
1
|
17
|
- Outd outdegree, the number of downstream signaling pathways connected to the node signaling pathway; Ind indegree, the number of upstream signaling pathways connected to node signaling pathway; Total degree: outdegree + indegree
